What is Pulmonx Corporation's EV / sales?

Pulmonx Corporation (LUNG) reported EV / sales of 0.6× in Q1 2026.

How has Pulmonx Corporation's EV / sales changed year-over-year?

Pulmonx Corporation's EV / sales decreased by 81.3% year-over-year, from 3× to 0.6×.

What is the long-term trend for Pulmonx Corporation's EV / sales?

Over 5 years (2020 to 2025), Pulmonx Corporation's EV / sales has grown at a -58.2% compound annual growth rate (CAGR), from 68.1× to 0.9×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Pulmonx Corporation LUNG EV / sales

EV / sales at other companies

Intuitive SurgicalISRG

19.6×-2.4×

Theravance BiopharmaTBPH

5.4×-0.5×

LQD

Liquidia CorporationLQDA

10.8×-66.6×

Viemed Healthcare, Inc.VMD

1.3×0.0×

Zevra Therapeutics, Inc.ZVRA

3.7×-6.9×

LivaNovaLIVN

2.3×+0.7×

Other financials

Income statement

See full

Revenue$20.6M-8.7%

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

See full

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

See full

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

See full

Market cap$54.91M-47.3%

Enterprise value$50.17M-43.5%

P/S0.6×-0.5×

Profitability

See full

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

See full

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Calculated from Pulmonx Corporation’s reported figures.

enterprise value/total revenue=0.6×

Based on the most recent quarter.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulmonx Corporation's EV / sales?: Pulmonx Corporation (LUNG) reported EV / sales of 0.6× in Q1 2026.
How has Pulmonx Corporation's EV / sales changed year-over-year?: Pulmonx Corporation's EV / sales decreased by 81.3% year-over-year, from 3× to 0.6×.
What is the long-term trend for Pulmonx Corporation's EV / sales?: Over 5 years (2020 to 2025), Pulmonx Corporation's EV / sales has grown at a -58.2% compound annual growth rate (CAGR), from 68.1× to 0.9×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.